The State Company for the Drugs Industry and Medical Appliances in Samarra addressed Sunday the Ministry of Health to support its prices and raise the volume of annual contracts with it, it revealed the size of contracts and the percentage of differences between the prices of its products and foreign products.

The company's director, Khaled Mohi Alwan, told the Iraqi News Agency (INA), that "the majority of the company's products, in addition to the raw materials, are of high quality and of solid European origin," noting that "the Iraqi medicines of Samarra is comparable to the foreign product in terms of quality."